Introduction {#s1}
============

In organisms with circular genomes, homologous recombination-mediated repair behind a stalled replication fork can join the two nascent daughter chromosomes, resulting in a chromosome dimer ([@bib7]). Dimer formation prohibits proper segregation of the genetic information at cell division ([Figure 1A](#fig1){ref-type="fig"}), and must be repaired to produce viable progeny. In bacteria and archaea, chromosome dimers are monomerized by members of a large family of tyrosine recombinases, the Xer recombinases ([@bib9], [@bib10]). These enzymes act by promoting recombination between two DNA sites, called *dif*. The *dif* site is normally present in a single copy at the replication terminus ([@bib13]; [@bib40]), but it is duplicated in chromosome dimers, so that intramolecular recombination results in separation ('resolution') of the two chromosome copies ([Figure 1A](#fig1){ref-type="fig"}). Removal of the *xer* genes or the *dif* site results in increased DNA content, activation of the SOS response, cell filamentation, and cell death ([@bib12]; [@bib17]; [@bib30]; [@bib55]; [@bib62]). Besides chromosome dimer resolution, Xer recombinases can support plasmid resolution and mobilization of the cholera toxin phage CTXϕ and pathogenicity islands ([@bib16]; [@bib23]).10.7554/eLife.19706.003Figure 1.Xer recombination.(**A**) The role of Xer recombination in the maintenance of bacterial chromosomes. Homologous recombination behind a stalled replication fork can result in a chromosome dimer. Xer recombinases monomerize these to rescue healthy genome segregation. The absence of Xer leads to cell division arrest and cell death. (**B**) Schematic representation of tyrosine site-specific recombination. Two recombinase monomers (beige ovals) bind one specific DNA site (grey) and two such sites are aligned in antiparallel in a tetrameric synaptic complex (**i**). The catalytic tyrosines of two symmetry-related protomers (red star) cleave one strand of each DNA, creating a covalent 3' phosphotyrosyl bond and a free 5' hydroxyl group (**ii**). The latter then attacks the phosphotyrosyl bond of the partner DNA, forming the HJ intermediate (**iii**). Following an isomerization step, the second pair of protomers becomes catalytically active (**iv**), leading to a reciprocal set of cleavage and strand exchange reactions that resolve the HJ and generate the recombined DNA products (**v--vi**). Only two protein subunits are active in the tetramer at a time ('half-of-the-sites reactivity'), strictly ordering the chemical steps to ensure faithful progression of the recombination reaction to the desired products. Note that the DNA substrates are drawn with the strand going 3' to 5' on the top.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.003](10.7554/eLife.19706.003)

In *E. coli*, Xer recombination is carried out by cooperation of two similar enzymes XerC and XerD (37% identity) that act together to bind and recombine *dif* sites ([@bib10]). Many other organisms (including *Lactococcus*, *Helicobacter*, *Campylobacter* spp. and archaea) employ a single Xer recombinase system ([@bib13]; [@bib15]; [@bib17]; [@bib41]; [@bib43]), with a prime example, XerH/*dif~H~*, found in *Helicobacter pylori*, a gastric pathogen implicated in peptic ulcer disease and gastric cancer.

Xer recombinases are members of the tyrosine site-specific recombinase superfamily, a large group of enzymes that catalyze DNA breakage and rejoining using a conserved tyrosine nucleophile ([@bib27]; [@bib28]; [@bib48]; [@bib51]). Tyrosine recombinases promote various programmed DNA rearrangements including the monomerization of phage, plasmid and chromosome multimers, resolution of hairpin telomeres, and the movement of virulence and antibiotic resistance carrying integrative mobile genetic elements (including phages and transposons)([@bib27]; [@bib32]; [@bib48]). In addition, tyrosine recombinases (as exemplified by Cre and Flp) provide powerful genetic engineering tools that are widely used to carry out mutagenesis and DNA insertion in eukaryotic chromosomes ([@bib49]; [@bib61]).

Tyrosine recombinases share a common chemical mechanism that involves step-wise breakage and exchange of four DNA strands in pairs, proceeding through a characteristic four-way Holliday junction (HJ) DNA intermediate ([Figure 1B](#fig1){ref-type="fig"})([@bib24]; [@bib27]; [@bib31]). They cut each DNA strand with a polarity creating a covalent 3' phosphotyrosyl protein-DNA linkage and a free 5' hydroxyl group. The DNA ends then go on to join with the complementary ends of the partner DNA strand generating the recombined products. All DNA cleavage and rejoining reactions take place in an ordered protein-DNA synaptic complex, comprising four recombinase molecules holding the two recombination partner DNA molecules together.

An unusual feature of Xer recombination at *dif* is that it requires an accessory factor, FtsK ([@bib5]; [@bib17]; [@bib41]; [@bib43]; [@bib50]; [@bib58]). This DNA motor protein localizes to the bacterial cell division septum and contributes to segregating the sister chromosomes into the daughter cells by translocating towards their replication termini. On chromosome dimers, FtsK stops at the Xer-bound *dif* sites and activates recombination, triggering resolution of the dimers to monomers ([@bib5]; [@bib26]; [@bib46]). Without FtsK, Xer-*dif* synaptic complexes are formed, but do not lead to final recombination products ([@bib5]; [@bib19]; [@bib26]; [@bib71]). Regulation by FtsK is critical to ensure that Xer recombination takes place only in the correct spatial and temporal context -- at the division septum, when genome replication has been completed -- thereby ensuring faithful genome segregation.

Here, we present two crystal structures of the *H. pylori* XerH recombinase in complex with its recombination site *dif~H~*. Together with associated biochemical and in vivo data, these first Xer-DNA complex structures shed light on potential regulatory mechanisms of the recombination pathway. Remarkably, the overall shape and DNA conformation of initially formed XerH-*dif~H~* synaptic complexes is considerably different from those of other tyrosine recombinases, such as Cre-*loxP* that has served as a model system for the family. The unanticipated conformation of the pre-cleavage synaptic complex suggests a possible model for why Xer proteins require external activation, and in comparison with the post-cleavage complex structure provides clues for how FtsK might stimulate recombination activity. Our structures provide a resource to construct models for other Xer synaptic complexes, including that of the heterotetrameric *E. coli* XerC/D system.

Results {#s2}
=======

Structure of the XerH-*dif~H~* synaptic complex {#s2-1}
-----------------------------------------------

The current mechanistic model of Xer recombination conforms to the tyrosine recombinase paradigm, which is supported by extensive biochemical and structural studies on Xer and other systems (reviewed in: \[[@bib27]; [@bib48]; [@bib63]\]). This model proposes a step-wise process that starts with two Xer monomers binding to each *dif* site, which then interact to form a synaptic complex ([Figure 1B, i](#fig1){ref-type="fig"}) ([@bib10]). Here, two Xer protomers each cleave one strand of one *dif* site ([Figure 1B ii](#fig1){ref-type="fig"}) ([@bib11]; [@bib24]; [@bib28]), and the broken strands are exchanged and rejoined creating the HJ intermediate ([Figure 1B, iii](#fig1){ref-type="fig"}) ([@bib25]). Then the second Xer pair performs cleavage and strand exchange on the other strand pair, completing recombination ([Figure 1B, v--vi](#fig1){ref-type="fig"}). Based on available synaptic complex structures of other tyrosine recombinases, it was hypothesized that the *dif* DNA is bent upon synapsis, creating a square planar DNA arrangement that is then maintained throughout the recombination reaction to allow energetically inexpensive exchange of DNA strands ([@bib25]; [@bib28], [@bib29]). However, in the absence of direct structural data the exact architecture of Xer-DNA complexes has remained unknown. Previous DNA-free crystal structures of Xer recombinases ([@bib33]; [@bib57]; [@bib59]) showed a domain arrangement that is incompatible with DNA binding. Another puzzling aspect of the mechanism concerned activation by FtsK. In early work, it was noted that in the absence of *E. coli* FtsK, HJ formation was catalysed by XerC, leading to the hypothesis that XerC/D-*dif* synaptic complexes assemble preferentially with XerC in an active conformation ([@bib6]). Subsequently, FtsK was shown to interact directly with the C-terminal domain of XerD ([@bib36]; [@bib69], [@bib70]), and this interaction was hypothesized to promote reassembly of the 'XerC-active' synaptic complex into a conformation in which XerD is active and performs cleavage of the first DNA strand pair ([@bib5]; [@bib26]; [@bib71]). More recently, single-molecule Fluorescence Resonance Energy Transfer (smFRET) studies indicated that the majority of XerC/D-*dif* synaptic complexes formed in the absence of FtsK are in a conformation where XerD is catalytically inactive, but ready for direct activation by FtsK without major dis- and reassembly of the complex ([@bib71]). A small proportion of XerC active complexes nevertheless form and create unproductive HJs, but the pre-active XerD synaptic complexes are dominant and are the ones activated by FtsK. However, none of the previous structures or biochemical data have provided an explanation for why Xer recombinases require activation, or what the nature of the proposed conformational rearrangements might be.

To begin to shed light on these issues, we determined the structure of *Helicobacter pylori* XerH in complex with its *dif~H~* DNA substrate. *dif~H~* ([Figure 2A](#fig2){ref-type="fig"}) was previously predicted by comparative genome analysis and consists of two XerH-binding arms separated by a 6 bp central region ([@bib13]). We confirmed XerH binding to *dif~H~* by DNase I footprinting ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) and analytical size exclusion chromatography (SEC) ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). We then co-crystallized full-length wild-type XerH with a 30 bp *dif~H~* DNA duplex. The resulting 2.1 Å resolution structure ([Figure 2B](#fig2){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}) shows a synaptic complex with two *dif~H~* molecules and four XerH subunits ([Figure 2B](#fig2){ref-type="fig"}, left panel). Each *dif~H~* site interacts with two XerH molecules, one molecule (molecule A) binding to the left arm and one (molecule B) to the right arm. The complex has overall two-fold symmetry relating the two DNA molecules and the XerH molecules bound to them (i.e. molecules A and B to A' and B'; [Figure 2B](#fig2){ref-type="fig"}). The overall fold of each protein subunit resembles that of other tyrosine recombinases, comprising two mostly helical domains connected by a 7-aa linker ([Figure 2C](#fig2){ref-type="fig"}). Notably, the C-terminal helix αO protrudes from the body of each catalytic domain into a cleft on the surface of an adjacent subunit in a cyclic fashion, creating a cyclic domain-swapped arrangement similar to the ones observed in the structures of Cre ([Figure 2B](#fig2){ref-type="fig"}, right panel) and λ integrase synaptic complexes ([@bib8]; [@bib28]).10.7554/eLife.19706.004Figure 2.Structure of the XerH-*dif~H~* complex.(**A**) Sequence of the *H. pylori dif~H~* site. The sequence is written in the 3' to 5' direction to maintain consistency with the historical nomenclature of the arms, the structural figures, and the schematic models. The two XerH-binding arms are shown in gold and blue and the central region and the terminal base-pairs in gray. The inserted base-pair in the left arm is shown in brown. Red arrows indicate XerH cleavage sites. Binding assays confirming the site are shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**B**) The XerH-*dif~H~* synaptic complex structure (left), compared to the previously solved Cre-*loxP* synaptic complex (PDB: 4CRX; right). XerH molecules are shown in cartoon representation, colored as their bound *dif~H~* arms in A (molecule A in gold, molecule B in blue). Red arrows indicate the cleavage sites on the DNA. Side arrows mark the synaptic interface. The dyad symmetry axis of the tetramer runs along the midline of the synaptic interface. See [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} for a snapshot of the electron density map. (**C**) Close-up of the left arm-bound XerH (molecule A, gold). The N-terminal domain (residues 1--163) consists of six α-helices (αA to αF, cylinders); helices αB and αC are XerH-specific. The C-terminal catalytic domain (residues 171--362) is also mostly helical (αG-αO), with a single β-sheet containing three antiparallel β-strands (brown arrows). The interdomain linker could not be located in the structure (dashed line). The catalytic tyrosine is shown in red. [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"} shows a comparison with the previously solved DNA-free structure of XerD. (**D**) Sequence-specific interactions of XerH (side chains shown as sticks with atomic coloring) and DNA. Hydrogen bonds (\<3.5 Å) are shown as dashed black lines. See [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"} for a comprehensive overview of the protein-DNA interactions and their biochemical validation.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.004](10.7554/eLife.19706.004)10.7554/eLife.19706.005Figure 2---figure supplement 1.XerH binding to the predicted *dif~H~* site.(**A**) DNase I footprinting assay mapping the XerH-protected region of *dif~H~*. A *dif~H~*-containing bottom strand-labeled DNA substrate was incubated with XerH and then digested with the indicated amounts of DNase I to reveal the XerH-protected region of the substrate. Sequencing ladders (G, A, T, and C) were run alongside the reactions. The sequence of the protected region is shown, with the two *dif~H~* arms shaded gray. (**B**) Analysis of complex formation between XerH and a 33 bp *dif~H~ *substrate by size-exclusion chromatography (SEC) detected at 260/280 nm. Retention volumes indicate formation of a complex with a larger size upon combining protein and DNA.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.005](10.7554/eLife.19706.005)10.7554/eLife.19706.006Figure 2---figure supplement 2.A cross-eyed stereo image of the bias-minimized 2Fo-Fc composite omit electron density map of the pre-cleavage XerH-*dif~H~* complex structure.The map (black mesh) shows the region of the active site of the left arm-bound subunit contoured at 1.2 sigma level. Protein (gold) and DNA (gray) residues are shown as sticks with atomic coloring; water molecules are shown as red spheres.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.006](10.7554/eLife.19706.006)10.7554/eLife.19706.007Figure 2---figure supplement 3.Comparison of the DNA-bound XerH (gold) and DNA-free XerD (PDB: 1A0P; green) structures.The insert shows how a rotation of the N-terminal domain (in rainbow coloring from blue for N-terminus to red for C-terminus) can lead to the opening of the XerD clamp in order to accommodate a DNA duplex without clashes.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.007](10.7554/eLife.19706.007)10.7554/eLife.19706.008Figure 2---figure supplement 4.Interactions between XerH and the *dif~H~* site.(**A**) Schematic view of the interactions observed in the XerH-*dif~H~* synaptic complex crystal structure. Amino acids of the XerH subunits bound to the left and right *dif~H~* arms are shown in gold and blue, respectively. The residues of the N-terminal domain are shown with a darker color, and the catalytic residues are shown in red. Dashed lines indicate hydrogen bonds. Bases directly contacted by XerH are colored gold or blue. Interacting water molecules are shown in grey. Red stars mark the cleavage sites. The diagram is based on protein-DNA interaction analysis performed with NUCPLOT ([@bib45]). (**B**) Mutational analysis of XerH-*dif~H~* interactions. The left-arm palindrome *dif~H~ *(*dif~H~*LP) substrate is shown on the left with the left arm sequences in gold. Note that the sequence is written in the 3' to 5' direction as in the main figure. Arrows beneath the sequence indicate the palindromic region, and triangles mark the introduced nicks. On the right, in vitro XerH cleavage assays with various substrate variants. The DNA mutations numbered as in (**A**) are indicated above the gel. In this assay, upon cleavage XerH becomes covalently attached to the cleaved DNA strand via a phosphotyrosyl bond, which is trapped by the use of double-nicked 'suicide' substrates (see schematic representation in [Figure 3C](#fig3){ref-type="fig"}). The XerH-DNA covalent intermediate and unmodified XerH can be separated on SDS-PAGE.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.008](10.7554/eLife.19706.008)10.7554/eLife.19706.009Table 1.X-ray diffraction data collection and refinement statistics.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.009](10.7554/eLife.19706.009)XerH-*dif~H~*XerH-*dif~H~*LP nativeXerH-*dif~H~*LP Se**Crystal properties**Space groupP 2~1~ 2~1~ 2~1~I 2 2 2I 2 2 2Unit cell: a, b, c (Å)79.28, 153.2, 169.3986.38, 115.22, 235.285.79, 115.73, 235.29Unit cell: α, β, γ (°)90, 90, 9090, 90, 9090, 90, 90**Data collection**BeamlineI04-1 (DLS)ID29 (ESRF)ID29 (ESRF)Wavelength (Å)0.928190.979080.97908Resolution range (Å)48.89--2.1 (2.18--2.1)46.96--2.4 (2.49--2.4)47.04--3.15 (3.2--3.15)Total reflections793843372682100854Unique reflections1206594621637960Multiplicity6.6 (6.0)8.1 (8.2)2.7 (2.6)Completeness (%)99.87 (99.81)99.86 (99.50)97.2 (96.2)R-meas (%)11.28 (82.4)10.32 (140.1)11.9 (71.0)R-sym (%)10.4 (75.4)9.7 (131.4)9.7 (58.2)I/σI12.53 (2.25)14.90 (1.51)11.17 (1.89)CC1/20.998 (0.754)0.999 (0.648)0.994 (0.727)Wilson B-factor31.5556.9759.75**Refinement**R-work0.19130.1949R-free0.22330.2203Number of non-hydrogen atoms146706984Protein residues1508769RMS (bonds)0.0030.002RMS (angles)0.530.55Ramachandran favored (%)9997Ramachandran outliers (%)00Clashscore1.922.99Average B-factor37.9072.20

Whereas the structure of individual XerH subunits is similar to that of other tyrosine recombinases, the arrangement of the subunits within the synaptic complex differs from that observed previously, forming a considerably less compact synaptic interface with a wide open central channel (illustrated by comparison with the 'paradigm' Cre-*loxP* structure in [Figure 2B](#fig2){ref-type="fig"}) ([@bib29]). Furthermore, the DNA molecules assume a near-straight conformation, in contrast to all previously reported tyrosine recombinase synaptic complexes.

Recognition of the *dif~H~* site {#s2-2}
--------------------------------

All four subunits of the XerH tetramer interact extensively with DNA. The two domains of each subunit form a tight, C-shaped clamp around one arm of the *dif~H~* site ([Figure 2C](#fig2){ref-type="fig"}). The N-terminal domain contacts the DNA using a four-helix bundle (αA-αD, aa 12--88) and helix αF, both of which insert into the major groove ([Figure 2C](#fig2){ref-type="fig"}). These protein segments contribute most of the sequence-specific interactions to the DNA bases, while the catalytic domain contacts mainly the DNA backbone ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). Many interactions of the catalytic domain involve helix αK (aa 285--299) that is inserted into the major groove at the outer part of *dif~H~*, narrows the groove (17 Å as opposed to 22 Å in typical B-DNA) and induces a slight DNA bend ([Figure 2C](#fig2){ref-type="fig"}). In addition, several contacts dispersed along the DNA backbone help to stabilize the position of the catalytic domain.

XerH covers 11 bp of the left *dif~H~ *arm and 10 bp of the right arm ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). The inner 5 bp of each arm (positions 7--11 and 20--24, [Figure 2A](#fig2){ref-type="fig"}) are recognized sequence-specifically ([Figure 2D](#fig2){ref-type="fig"}), while the outer nucleotides (positions 2--4 and 26--28) are mostly contacted at the phosphate backbone. The central region is only involved in sparse backbone interactions ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). To confirm the importance of the *dif~H~ *DNA sequence, we performed cleavage assays with 'suicide' *dif~H~* substrates ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}). These substrates contain a nick in the DNA backbone of each strand, one nucleotide downstream of the cleavage position. Upon XerH-mediated cleavage, the resulting covalent XerH-*dif~H~* intermediate is trapped and can be detected by SDS-PAGE (see also [Figure 3C](#fig3){ref-type="fig"}). As predicted by the structure, mutations of the inner base-pairs of the arms (where XerH makes base-specific contacts) resulted in abolished or greatly reduced cleavage activity, whereas mutations of the neighboring base-pairs did not affect the activity.10.7554/eLife.19706.010Figure 3.Differential recognition of the two *dif~H~* arms.(**A**) XerH binding to *dif~H~* and derivatives containing a single *dif~H~* arm (*dif~H~*L or *dif~H~*R) flanked by a random sequence, as quantified from EMSA (see original gels in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and numerical quantification data in [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). Random DNA was used as a control. (**B**) SEC of XerH complexes with palindromic *dif~H~ *substrates (left-arm palindrome *dif~H~*LP, right-arm palindrome *dif~H~*RP). XerH alone migrates as a monomer. A shift in retention is observed with *dif~H~*LP, indicating stable complex formation. No corresponding shift is seen with *dif~H~*RP. (**C**) The design of the in vitro cleavage assay using nicked 'suicide' substrates: upon cleavage by XerH, a single nucleotide diffuses away trapping the covalent phosphotyrosyl intermediate. (**D**) In vitro DNA cleavage assays, showing that the left arm of *dif~H~* is required for XerH activity. The covalent protein-DNA intermediate is detected by SDS-PAGE. (**E**) Left arm is required for XerH-mediated recombination in *E. coli*. Intramolecular recombination rates were measured with plasmids containing two *dif~H~* sites (WT+WT), one *dif~H~* site and one *dif~H~*LP site (WT+LP), two *dif~H~*LP sites (LP+LP), one *dif~H~* site and one *dif~H~*RP site (WT+RP), two *dif~H~*RP sites (RP+RP), two *dif~H~* sites with G3 and T4 mutated to CA, or two *dif~H~* sites with G3 and T4 mutated to CC. G3 was mutated together with T4, because it may interact with K290 and complement the role of T4. XerH catalytic mutant R213K XerH is shown as a control. Bars indicate standard deviation determined from three independent experiments (n = 3). \*\*p\<0.05 (Student's test). Colony counts and recombination rates are tabulated and their statistical analysis is shown in [Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"}. (**F**) XerH recognizes the left (gold) and right (blue) *dif~H~* arms differently. Superimposition of two adjacent XerH subunits shows differences in the DNA bending, in the positions of the C-terminal domains, and in the protruding helices αO. Red insert: Interaction of K290 and T4 (dashed lines: hydrogen bonds) at the left arm (left panel) is absent at the right arm (right panel). Black insert: Interactions with the three outermost base-pairs of the left (top) and the right (bottom) *dif~H~* arms are remarkably similar despite the shifted DNA sequence. Functional characterization of these interactions and the role of the specific features of the left *dif~H~* arm are shown in [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}. (**G**) Active site conformations at the left (gold) and right (blue) *dif~H~* arm. Catalytic residues (sticks) are incompletely assembled around the scissile phosphates (orange spheres). The red sphere denotes a bound water molecule.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.010](10.7554/eLife.19706.010)10.7554/eLife.19706.011Figure 3---source data 1.Quantification of XerH binding to *dif~H~* variants based on EMSA experiments.The original gels are shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.011](10.7554/eLife.19706.011)10.7554/eLife.19706.012Figure 3---source data 2.Results of the in vivo recombination assays.Colony counts and recombination rates are tabulated and their statistical analysis by Student's t-test is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.012](10.7554/eLife.19706.012)10.7554/eLife.19706.013Figure 3---figure supplement 1.Electrophoretic mobility shift assay (EMSA) gels showing XerH binding to *dif~H~* and derivatives.EMSA was performed with 50 bp substrates containing wild-type *dif~H~* (**A**), left arm of *dif~H~* accompanied by a random sequence (**B**), right arm of *dif~H~* preceded by a random sequence (**C**), or a fully randomized sequence with matched GC content (**D**). The resulting bands correspond to free DNA, DNA bound to one XerH monomer (gray oval), or DNA bound to two XerH monomers, as indicated by the schematics on the right hand side of the gels. These complex stoichiometries are derived from analytical SEC and supported by EMSA with half-site *dif~H~* DNA (data not shown).**DOI:** [http://dx.doi.org/10.7554/eLife.19706.013](10.7554/eLife.19706.013)10.7554/eLife.19706.014Figure 3---figure supplement 2.Functional characterization of the role of the specific features of the left *dif~H~* arm.(**A**) Cleavage assays with *dif~H~*LP derivatives modified at the inserted base-pair (positions 6/25', brown). The figure illustrates the unmodified substrate (written in the 3' to 5' direction), nicked at the two positions marked by black wedges. Upon cleavage, XerH becomes covalently attached to DNA via a phosphotyrosyl bond, which is separated from unmodified XerH on SDS-PAGE (see also [Figure 3C](#fig3){ref-type="fig"}). (**B**) Mutations of the inserted base in the left arm do not affect XerH-mediated recombination in *E. coli. galK* reporter plasmids contained two wild-type *dif~H~* sites (A--WT) or two *dif~H~* sites with the left arm mutated at position 6/25' (A6 mutated to G, C, or T as indicated). Bars indicate standard deviation (n = 3). None of the mutations showed significant reduction of recombination (p\>0.05; Student\'s test). Exact colony counts, recombination rates, and their statistical analysis are shown in [Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"}. (**C**) K290S mutation does not affect *dif~H~* binding (WT: wild-type XerH control). Binding curves were quantified from EMSA (see numerical data in [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). (**D**) K290S mutation reduces XerH recombination in *E. coli* by 50% (WT: control assay with wild-type XerH). Reporter plasmids contained two wild-type *dif~H~* sites. Statistical analysis is as in (**B**). \*\*p\<0.05 (Student's test). Colony counts, recombination rates, and statistical analysis are included in [Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.014](10.7554/eLife.19706.014)

In contrast to the previously described DNA-free structure of XerD ([@bib59]), the N-terminal and catalytic domains of XerH are positioned such that the cleft formed between their inner surfaces readily accommodates the *dif~H~* DNA in a conformation that resembles DNA-bound structures of other tyrosine recombinases ([@bib3]; [@bib14]; [@bib28]). A simple rotation of the N-terminal domain pivoting at the interdomain linker is sufficient to transition from the 'closed' XerD conformation to the 'open' DNA-bound XerH conformation ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), consistent with previous proposals that Xer recombinases may undergo a major conformational change upon DNA binding ([@bib33]; [@bib57]; [@bib59]).

*dif~H~* asymmetry dictates the order of binding and cleavage events {#s2-3}
--------------------------------------------------------------------

One of the hallmarks of tyrosine recombination is that the DNA strands are exchanged step-wise in a strictly ordered manner. In several studied examples, this ordering is believed to be linked to asymmetry in the DNA sequences, but the exact mechanisms vary ([@bib10]; [@bib22]; [@bib50]). To determine how the XerH-*dif~H~* system achieves ordering of the recombination steps, we first tested the roles of the two distinct protein-binding arms of *dif~H~* ([Figure 2A](#fig2){ref-type="fig"}) in XerH binding and activity. DNA binding assays (EMSA) with substrates containing the sequences of one or both arms ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) showed that two XerH monomers bind cooperatively (see especially [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). The affinity of a *dif~H~*L substrate containing only the left arm sequence, with a random sequence in place of the right arm, was higher (dissociation constant, K~D~ = 180 nM; similar to wild-type *dif~H~* K~D~ = 150 nM) than the affinity of a similar right arm-containing substrate *dif~H~*R (K~D~ = 230 nM). Similarly, a palindromic substrate containing two *dif~H~* left arms (*dif~H~*LP) made a stable complex with XerH (observed by SEC), whereas the equivalent right arm substrate (*dif~H~*RP) did not ([Figure 3B](#fig3){ref-type="fig"}). DNA cleavage assays also revealed different efficiencies at the two arms: no cleavage product was detected with *dif~H~*R or *dif~H~*RP, whereas *dif~H~*L and *dif~H~*LP substrates were cleaved as efficiently as the native *dif~H~* site ([Figure 3C and D](#fig3){ref-type="fig"}). An assay that assesses the efficiency of intramolecular recombination between two plasmid-borne sites in *E. coli* also indicated differential activity at the two *dif~H~* arms in vivo: the wild-type recombination rate (9.9% recombination-positive colonies) increased when both *dif~H~* sites were replaced with *dif~H~*LP (29.4%; p=0.0016, t-test), but decreased to barely detectable levels with *dif~H~*RP (1.3%; p=0.0021, t-test) ([Figure 3E](#fig3){ref-type="fig"}).

Our observation that XerH binds and preferentially cleaves the left arm of *dif~H~* led us to ask how the arms are distinguished. Remarkably, the sequences of the two arms are identical apart from a single base-pair insertion in the left arm ([Figure 2A](#fig2){ref-type="fig"}). In the crystal structure, the respective XerH subunits (A and B) make very similar interactions with the two *dif~H~* arms ([Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). The inserted base-pair (A6/T25', brown in [Figure 2A](#fig2){ref-type="fig"}) is not recognized directly. Instead, the main difference in the recognition of the two arms involves a conserved thymine base (T4/T5\') in the outer parts of the arms: In the left arm, T4 forms hydrophobic contacts with XerH αK and makes a specific hydrogen bond with lysine K290 ([Figure 3F](#fig3){ref-type="fig"}, red insert), whereas in the right arm T5\' is closer to the center of *dif~H~* and cannot make these interactions. Surprisingly, the three outermost base-pairs of each *dif~H~* arm make very similar backbone interactions with their respective XerH subunits, despite the fact that they are shifted in space due to the insertion in the left arm (altering the 'helical phase' of the sequence by \~35°; [Figure 3F](#fig3){ref-type="fig"}, black insert; [Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}). This is possible because the conformation of the DNA is asymmetric -- the left arm is more bent than the right arm -- and the catalytic domains of the protein subunits are rotated by \~10° relative to each other ([Figure 3F](#fig3){ref-type="fig"}). Together, the observed differences result in stronger interaction of XerH with the left *dif~H~* arm (ΔG = −21.3 kcal/mol, estimated by PISA \[[@bib39]\]) than with the right arm (ΔG = −15.4 kcal/mol). A further difference between the XerH subunits bound to the left and right arms of *dif~H~* concerns the C-terminal helices. While the αN-αO segment of molecule A is fully ordered, the linker and αO are partially disordered in molecule B. Also, helices αO point in different directions (\~100° rotation; [Figure 3F](#fig3){ref-type="fig"}).

In agreement with the structure, *dif~H~* variants containing mutations at the inserted base-pair showed no or only moderate decreases in cleavage in vitro ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}) and recombination in vivo ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). In contrast, substitutions of T4 practically abolished recombination in *E. coli* ([Figure 3E](#fig3){ref-type="fig"}) and in *H. pylori* ([@bib17]); and mutation of K290 (K290S) decreased recombination activity by about half ([Figure 3---figure supplement 2D](#fig3s2){ref-type="fig"}). Insertion of an additional base-pair next to A6/T25' in the left arm, further shifting the positions of the three outermost base-pairs, also abolished cleavage completely ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}).

Like the arms, the central region of *dif~H~* is also asymmetric, with different nucleotides flanking the left and right cleavage sites (positions C13 and G13'). However, XerH does not contact these nucleotides in our structure, and cleavage assays with *dif~H~* variants carrying mutations at these positions revealed no reduction in activity ([Figure 2---figure supplement 4B](#fig2s4){ref-type="fig"}), suggesting that the identity of these nucleotides does not contribute to XerH binding and cleavage asymmetry.

Together, these data demonstrate that XerH binds preferentially to the left arm of *dif~H~* thanks to favorable interactions with its outer sequence (including T4). Asymmetric interactions with the two arms of *dif~H~* also appear to dictate distinct protein conformations in the synaptic complex, including differential positioning of the αN-αO segment that carries the nucleophilic tyrosine, perhaps helping to define which arm is cleaved first.

A catalytically inactive, pre-cleavage synaptic complex, with almost straight DNA {#s2-4}
---------------------------------------------------------------------------------

Perhaps the most unexpected feature of the XerH-*dif~H~* synaptic complex structure is the DNA conformation, which is nearly straight. Both DNA molecules in the synapse resemble B-form DNA, with a wide angle (165°) between the two *dif~H~* arms ([Figure 2B](#fig2){ref-type="fig"}, left panel). This is in sharp contrast to other currently available DNA-bound structures of tyrosine recombinases, all of which contain strongly bent DNA. For example, the *loxP* DNA is bent to \~100° in the analogous pre-cleavage structures of Cre-*loxP* complexes ([Figure 2B](#fig2){ref-type="fig"}, right panel). This bent DNA conformation is maintained throughout the recombination reaction, allowing easy transition between the reaction intermediates ([@bib22]; [@bib25]; [@bib29]) (see also [Figure 1B](#fig1){ref-type="fig"}).

In the active site of each XerH subunit, several conserved residues including the catalytic tyrosine Y344, two arginine (R213 and R312), and two histidine (H309 and H335) residues are assembled around the scissile phosphate, together forming a catalytic pocket characteristic of tyrosine recombinases. The active sites of the subunits are very similar, except for the R213 side chain which points in different directions in molecules A and B ([Figure 3G](#fig3){ref-type="fig"}). Electron density for another essential catalytic residue, K239, could not be observed in either of the subunits, so we presume that it is disordered. The catalytic tyrosine Y344 is far away (5.2--5.8 Å) from the scissile phosphate in all subunits, so the structure represents a catalytically inactive synaptic complex, implying a conformational change is required prior to catalysis.

Conformational rearrangements in the post-cleavage synaptic complex {#s2-5}
-------------------------------------------------------------------

To capture XerH in a post-cleavage synaptic complex, we used 'suicide' *dif~H~* substrates (containing a nick in each DNA strand, as in the in vitro cleavage assays described above, [Figure 3C](#fig3){ref-type="fig"}). Attempts to co-crystallize XerH with suicide versions of the native *dif~H~* sequence were unsuccessful, but palindromic *dif~H~*LP suicide substrates gave us crystals that diffracted to 2.4 Å ([Table 1](#tbl1){ref-type="table"}).

The resulting structure ([Figure 4A](#fig4){ref-type="fig"}) differs considerably from the pre-cleavage structure. Each *dif~H~*LP site interacts with two XerH molecules in a tetrameric synaptic complex, but in this structure, the two halves of the tetramer are related by crystallographic two-fold symmetry (relating molecule A to A' and B to B'; [Figure 4A](#fig4){ref-type="fig"}). While the structures of the individual XerH subunits and their interactions with the respective *dif~H~* DNA arms in this structure and in the pre-cleavage structure are similar, the overall arrangement of the complex is different. Most strikingly, the *dif~H~* DNA is now strongly bent ([Figure 4B](#fig4){ref-type="fig"}, [Video 1](#media1){ref-type="other"}). The bend mainly originates from a single distortion within the central region of *dif~H~*: bases A17' and G18' are un-stacked with a 90° tilt, which introduces a kink resulting in asymmetric bending of the DNA (insert in [Figure 4B](#fig4){ref-type="fig"}). The total angle of 120° between the *dif~H~* arms is only slightly wider than the angles observed in previous structures of various tyrosine recombinases (e.g. 109° in the post-cleavage structure of λ integrase ([@bib8]) and 100° in Cre-*loxP* ([@bib28]); see also [Figure 2B](#fig2){ref-type="fig"}). Notably, the kink in *dif~H~* is at an equivalent position to the kink in *loxP* ([@bib22]). However, whereas in Cre the nucleotides involved in the kink interact with three arginines within a tight pocket ([Figure 4C](#fig4){ref-type="fig"}) ([@bib22]; [@bib28]), XerH forms only a single interaction with these nucleotides (R129-A17'; [Figure 4C](#fig4){ref-type="fig"}; [Figure 2---figure supplement 4A](#fig2s4){ref-type="fig"}) and encircles the kink less tightly. Notably, the nucleotides of the central region of *dif~H~* remain fully base-paired after cleavage, unlike the analogous structure of Cre-*loxP*, where several of these are unpaired ([@bib28]). The extensive Cre contacts can thus actively bend *loxP*. In contrast, weaker XerH-*dif~H~* interactions appear to be insufficient to promote sharp DNA bending, but nicks in both DNA strands of the *dif~H~* substrate facilitate bending. When we tried to re-build the DNA strands in the post-cleavage structure to model a bent but un-nicked substrate, we observed a clash with the protein near the tyrosine nucleophile-bearing helix αN, suggesting that the nicks might favor the XerH conformation adopted on the bent sites.10.7554/eLife.19706.015Figure 4.The post-cleavage XerH-*dif~H~*LP synaptic complex structure.(**A**) Overall view of the XerH-*dif~H~*LP structure in cartoon representation. Sequence of the *dif~H~*LP substrate is shown above (written in the 3' to 5' direction, with the arms in gold, central region in gray) the nick positions are marked by triangles. [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} shows a snapshot of the electron density map. (**B**) Compared to the pre-cleavage XerH-*dif~H~* complex, both subunits (A, gold; B, blue surface) have rotated \~22° towards each other, concomitant with DNA bending. Insert: Close-up of DNA bending: A17' and G18' (red) are unstacked, with a 90° kink. (**C**) XerH (left) interacts with the DNA kink differently than Cre (PDB: 1NZB; right). The electrostatic surface potential is shown in red (negative) and blue (positive). (**D**) Superimposition of the two subunits (A, gold and B, blue) bound to the same *dif~H~*LP site illustrates their different conformations. Left insert: Helices αN and αO are repositioned relative to the pre-cleavage structure (grey), including rotations (marked by arrows) and shortening of the helices (red dashed lines showing the distances between Cα of L338 and Cα of W359). Right insert: repositioning of the β2-β3 loop upon activation enables the catalytic K239 to interact with the DNA. For clarity, only the DNA associated with the golden monomer is shown. (**E**) Active site conformations of the distinct XerH subunits. In the active subunit (molecule A, left), R213, H309, R312, and H335 make hydrogen bonds with the scissile phosphate (orange), K239 contacts the base of the adjacent nucleotide A12, and Y344 is covalently attached to the DNA. In the inactive subunit (right) the catalytic tyrosine is 5.5 Å away from the scissile phosphate, R213 and H335 point away, and the K239 side chain is disordered. Red sphere -- bound water molecule; dashed lines -- hydrogen bonds.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.015](10.7554/eLife.19706.015)10.7554/eLife.19706.016Figure 4---figure supplement 1.Cross-eyed stereo image of the bias-minimized 2Fo-Fc composite omit electron density map of the post-cleavage XerH-*dif~H~* complex structure.The map (black mesh) shows the region of the active site of the active subunit contoured at 1.2 sigma level. Protein (gold) and DNA (gray) residues are shown as sticks with atomic coloring; water molecules are shown as red spheres.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.016](10.7554/eLife.19706.016)Video 1.Activation of the XerH-*dif~H~* synaptic complex.Morphing of the XerH-*dif~H~* synaptic complex in pre-cleavage conformation into the post-cleavage conformation. Activation involves major conformational rearrangement of the synaptic complex, involving rotation of all XerH subunits and sharp DNA bending.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.017](10.7554/eLife.19706.017)10.7554/eLife.19706.017

The arrangement of the XerH subunits is also markedly different in the two structures. Each subunit is rotated by \~22° in the post-cleavage structure ([Figure 4B](#fig4){ref-type="fig"}, [Video 1](#media1){ref-type="other"}), resulting in major rewiring of the inter-subunit interactions and an overall compaction of the complex. Also, the synaptic interface is considerably larger (3926 Å^2^, calculated by PISA \[[@bib39]\]) than in the pre-cleavage structure (3040 Å^2^). The previously disordered parts of the αO helices of molecule B are now fully visible, ordered, and more compact (F338 - W359 distance reduced from 43 Å to 34 Å; [Figure 4D](#fig4){ref-type="fig"}, left insert). At the same time, helices αN and αO of molecule A are rotated by \~30°, bringing the catalytic Y344 to a suitable position to attack one strand on each *dif~H~*LP DNA forming a covalent phosphotyrosyl bond ([Figure 4E](#fig4){ref-type="fig"}, left).

Interestingly, despite the symmetry of the palindromic *dif~H~*LP substrate, the two bound XerH molecules (A and B) are in different conformations ([Figure 4D](#fig4){ref-type="fig"}). Their overall structures are similar (r.m.s. deviation 0.78 Å for Cα carbons), but important protein segments that contain catalytic residues (the β2-β3 turn with K239, and αN-αO carrying Y344) are in different conformations ([Figure 4D](#fig4){ref-type="fig"}). Consequently, subunit A assumes a fully active conformation, while subunit B is in an inactive conformation with the catalytic tyrosine distant from the scissile phosphate ([Figure 4E](#fig4){ref-type="fig"}). This simultaneous presence of both active and inactive XerH subunit conformations within the synaptic complex is consistent with the 'half-of-the-sites reactivity' mechanism observed for other tyrosine recombinases ([Figure 1B](#fig1){ref-type="fig"}). The marked difference between the XerH subunits bound to the two *dif~H~*LP arms (comparable to the asymmetry seen in the pre-cleavage complex with native *dif~H~*) is particularly striking considering that the artificially introduced symmetry of the substrate could be expected to mask some asymmetric features of the synaptic complex. The asymmetry is presumably an intrinsic property of the system, essential to the mechanism of synapsis and catalysis.

Modeling of *E. coli* XerC/D synaptic complex based on the XerH-*dif~H~ *structures {#s2-6}
-----------------------------------------------------------------------------------

Due to high structural conservation within the Xer family ([@bib59]) ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}), our XerH structures can provide insights into the mechanisms of other Xer recombinases that have eluded structural studies so far. We have used our structures to model the heterotetrameric synaptic complex of *E. coli* XerC/D in both pre- and post-cleavage states ([Figure 5A](#fig5){ref-type="fig"}). We modeled DNA-bound XerC and XerD using the DNA-free XerD structure (PDB: 1A0P; ([@bib59])) and a homology model for XerC. These were then superimposed onto the XerH-*dif~H~* structures to assemble heterotetramers. Our models place XerC on the right arm of *dif~H~* and XerD on the left arm. We cannot exclude the alternative assignment, but our observation that XerH preferentially cleaves at the left arm of *dif~H~* first ([Figure 3D](#fig3){ref-type="fig"}) supports the hypothesis that the XerH subunit on the left arm corresponds to XerD whereas the subunit on the right arm corresponds to XerC.10.7554/eLife.19706.018Figure 5.XerC/D-*dif* synaptic complex models reveal common features of Xer recombination.(**A**) Cartoon representation of heterotetrameric XerC/D-*dif* synaptic complexes modeled based on the pre-cleavage (left) or the post-cleavage (right) XerH-*dif~H~ *complexes. XerD (green) and XerC (yellow) monomers are arranged compatibly in the tetramers. [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} shows the structure-based sequence alignment and a comparison of protein-DNA interactions. (**B**) Superimposition of XerD and XerC monomers in the pre-cleavage structure model. (**C**) Conserved active site residues of XerD and XerC (sticks with atomic coloring) are assembled around the scissile phosphate (orange) in the pre-cleavage XerC/D-*dif* synaptic complex.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.018](10.7554/eLife.19706.018)10.7554/eLife.19706.019Figure 5---figure supplement 1.Modeling of XerC/D-*dif* synaptic complexes.(**A**) Secondary structure-based alignment of XerH, XerD, and XerC. α-helices and β strands are marked above, conserved catalytic residues are in red. (**B**) Schematic view of the interactions of XerH, XerD, and XerC with the outer base-pairs of their respective binding sites. Dashes indicate hydrogen bonds.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.019](10.7554/eLife.19706.019)

In the models, the XerC and XerD monomers each form C-shaped clamps around one arm of the *dif* site ([Figure 5B](#fig5){ref-type="fig"}), and make multiple sequence-specific and backbone interactions with the DNA. The overall fold and conformation of the two proteins are very similar; only their C-terminal helices assume different relative orientations, as is also seen in the XerH structures. The five conserved catalytic residues (RHRHY) assemble around the catalytic pocket in all XerC and XerD subunits ([Figure 5C](#fig5){ref-type="fig"}). In the post-cleavage complex, the XerD subunits are in an active conformation, with their nucleophilic tyrosines approaching the scissile phosphates, whereas the XerC subunits are in an inactive conformation. As in the XerH structures, the three outer base-pairs of each *dif* arm are contacted extensively by the proteins ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), and the bases corresponding to T4 in *dif~H~* interact with lysine K222 of XerC or histidine H225 of XerD, both counterparts of XerH K290 ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). These interactions might contribute to the arm specificity of XerC and XerD, as well as to ordering recombination, as we inferred for XerH. The interactions involved in DNA kinking in Cre are absent in the XerC/D-*dif* complex, suggesting that these enzymes, like XerH, might be unable to independently initiate sharp DNA bending.

The protein arrangements and interfaces observed in our two XerH-*dif~H~* structures are well accommodated by XerC and XerD, the pre-cleavage model showing nearly straight DNA and the post-cleavage model containing bent DNA and tightened intersubunit interactions ([Figure 5A](#fig5){ref-type="fig"}). This suggests that the XerC/D and XerH complexes might undergo similar conformational rearrangements upon activation. In agreement with this idea, two previous smFRET studies ([@bib19]; [@bib71]) reported that pre-formed XerC/D-*dif* synaptic complexes undergo conformational change upon activation by FtsK, leading to an increase of the distance between the two *dif* termini from about 53 to 67 Å across the synapse (as predicted from a change in FRET efficiencies; \[[@bib71]\]). Our XerC/D-*dif* models predict a similar change from 46 Å in the pre-cleavage state to 60 Å in the post-cleavage state.

Discussion {#s3}
==========

In this work, we investigated the structural and mechanistic bases of Xer site-specific recombination. Using the homomeric XerH-*dif~H~* system from *H. pylori* as a model system, we report the first high-resolution crystal structures of Xer-*dif* synaptic complexes. These structures demonstrate that Xer proteins follow the established chemical pathway of tyrosine recombinases and reveal how the reaction steps can be choreographed by small differences in the arms of the *dif~H~* recombination sites. Together with associated biochemical data, the structures also show that XerH-*dif~H~* synaptic complexes initially assemble in an inactive state with straight DNA, which must undergo a major conformational change for catalytic activation, as previously observed in single molecule fluorescence studies of XerC/D-*dif* recombination ([@bib19]; [@bib71]). Our post-cleavage XerH-*dif~H~* synaptic complex structure elucidates the structural nature of this conformational change, which involves major rearrangement of the protein-protein interfaces and DNA bending ([Video 1](#media1){ref-type="other"}). With molecular modeling, we extend our structural and mechanistic findings to the prototypical *E. coli* XerC/D-*dif* system, demonstrating that our structures provide a resource for understanding the mechanism of other Xer recombinases.

The thoroughly characterized Cre site-specific recombination reaction has long been considered a paradigm for tyrosine recombinase-based DNA rearrangements ([@bib24]; [@bib27]; [@bib28]; [@bib64]). Unusually, Xer recombinases require an external factor (generally the cell division protein FtsK) for catalytic activation. This feature is essential for Xer's chromosome maintenance function, but does not have any analogy in the Cre system. Therefore, the structural basis of Xer recombination and its activation have remained debated. From our structural, biochemical, and microbiological data on *H. pylori* XerH-*dif~H~* recombination we can now propose a mechanistic model for XerH recombination and the regulatory function of FtsK, as follows ([Figure 6](#fig6){ref-type="fig"}):10.7554/eLife.19706.020Figure 6.Model for XerH recombination activation.(**A--C**) Differential binding affinities of XerH to the left and right arms of *dif~H~* DNA trigger an asymmetric DNA conformation and arrange the two protein subunits in distinct conformations (**A**). Two *dif~H~* sites are brought together in a tetrameric synaptic complex (**B**) stabilized by a cyclic arrangement of the protruding αO helices. Initially formed XerH-*dif~H~* complexes are inactive (indicated by gray nucleophilic tyrosine) as seen in our pre-cleavage structure. [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} shows that XerH alone is unable to cleave an intact DNA substrate. Catalytic activation then involves DNA bending and a major rearrangement of the protein subunits (as in our post-cleavage structure), presumably enabled by a direct interaction with FtsK (**C**). As a result, helices αO become ordered across the synapse, while helices αN and αO along one *dif~H~* molecule rotate, bringing the nucleophilic Y344 into the active conformation (yellow) that enables DNA cleavage. Note that the DNA substrates are drawn with the strand going 3' to 5' on the top as in [Figure 1B](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.020](10.7554/eLife.19706.020)10.7554/eLife.19706.021Figure 6---figure supplement 1.XerH activity on intact and nicked *dif~H~* substrates.XerH is unable to cleave intact *dif~H~* substrates, as assessed by DNA cleavage assays on SDS-PAGE. Wild-type *dif~H~* with or without 'suicide' nicks was used as indicated. (-) denotes no-DNA control.**DOI:** [http://dx.doi.org/10.7554/eLife.19706.021](10.7554/eLife.19706.021)

The recombination process starts with XerH binding to the *dif~H~* site on the *H. pylori* chromosome ([Figure 6A](#fig6){ref-type="fig"}). Two XerH subunits bind cooperatively to one *dif~H~* site ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}; [Figure 6A](#fig6){ref-type="fig"}), each forming a clamp around one arm of *dif~H~* ([Figure 2C](#fig2){ref-type="fig"}). The *dif~H~* left arm has higher affinity for XerH than the right arm ([Figure 3A,B](#fig3){ref-type="fig"}), leading to the second XerH molecule binding to the right arm more often than vice versa. Cooperative binding of XerH involves extensive contacts between the two subunits bound to each *dif~H~*, as revealed by our structures (1650.6 Å^2^ surface area with ΔG = −12.6 kcal/mol and 1515.5 Å^2^ with ΔG = −14.5 kcal/mol between molecules A-B and A'-B' respectively in the pre-cleavage structure; and 1379.8 Å^2^ surface area with ΔG of −13.8 kcal/mol in the post-cleavage structure). Despite the near-perfect dyad symmetry of the *dif~H~* arms, the bound XerH subunits are structurally distinct. The left arm subunit assumes a conformation primed for DNA cleavage, whereas the right arm subunit is forced in an inactive state. This asymmetric configuration defines the order of all subsequent cleavage and strand transfer events.

Two XerH-bound *dif~H~* sites then interact to create a tetrameric synaptic complex, as we see in our crystal structures ([Figure 2B](#fig2){ref-type="fig"}; [Figure 6B](#fig6){ref-type="fig"}). The sites align in antiparallel, and intersubunit interactions across the synaptic interface anchor the αO helices of the right arm-bound XerH subunits on their left arm-bound partner, creating a 'circular' domain-swapped arrangement, similar to the ones described for other tyrosine recombinases such as Cre and λ integrase ([@bib8]; [@bib28]).

The pre-cleavage synaptic complex crystal structure contains nearly straight *dif~H~* DNA ([Figure 2B](#fig2){ref-type="fig"}; [Figure 6B](#fig6){ref-type="fig"}), and XerH is in a catalytically inactive conformation ([Figure 3G](#fig3){ref-type="fig"}). Correspondingly, we were unable to observe *dif~H~* recombination or XerH-mediated cleavage of intact *dif~H~* DNA substrates in vitro ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}, and data not shown). We cannot exclude the possibility that XerH does still catalyze transient strand cleavage of these substrates, followed by rapid efficient re-ligation making cleavage undetectable, but there is no evidence to support this idea. In contrast, nicked *dif~H~* suicide substrates are cleaved efficiently, and our crystal structure in which XerH-mediated cleavage of nicked *dif~H~* has occurred showed a sharply bent DNA conformation, consistent with a direct link between DNA bending and cleavage activity. The crystals giving our two structures were grown under different conditions (see Materials and methods), but XerH was active (on nicked *dif~H~* substrates) in both conditions (data not shown), supporting our view that both structures are biologically relevant. We hypothesize that our in vitro systems lack a stimulatory factor that is required for normal recombination between intact *dif~H~* sites. Septum-borne FtsK was shown to be required for XerH recombination in *H. pylori* ([@bib17]), so we propose that this is the missing factor for XerH activation in vitro. FtsK-promoted rearrangement of the XerH-*dif~H~* synaptic complex might bring the catalytic tyrosines of the left arm-bound subunits into their active positions close to the scissile phosphates and sharply bend the DNA as seen in our structures ([Figures 4B](#fig4){ref-type="fig"} and [6C](#fig6){ref-type="fig"}; [Video 1](#media1){ref-type="other"}). Another possibility is that FtsK mediates formation of a different synaptic complex with the right arm-bound subunits activated for cleavage. However, this would be inconsistent with smFRET studies of XerC/D complexes showing that FtsK activates pre-formed synaptic complexes without major remodeling ([@bib71]). Analogy with the XerC/D system suggests that FtsK might directly interact with the C-terminal \~20 amino acids of XerH ([@bib70]) or the back of its C-terminal domain ([@bib36]). However, the role of FtsK in the *H. pylori* Xer system still requires further substantial investigation, and it remains possible that the bent-DNA configuration required for DNA cleavage can be reached from the pre-cleavage structure without the intervention of FtsK.

Following activation, XerH-catalysed DNA strand cleavage and rejoining presumably follow the conserved tyrosine recombination pathway ([Figure 1B](#fig1){ref-type="fig"}), with the XerH subunits bound to the left arms performing the first strand exchanges. The resulting HJ is then resolved by a reciprocal set of chemical reactions catalysed by the XerH subunits bound to the right arms.

DNA bending is a prerequisite for activity of many molecular machines, including transcription factors, topoisomerases and recombinases ([@bib20]; [@bib38]; [@bib42]; [@bib68]). In most of these cases, DNA bending and the downstream function are performed by the same protein or complex, or DNA bending depends on ubiquitously available factors such as IHF. For tyrosine recombinases, the paradigm suggests that sharp DNA bending that is required for DNA cleavage and energetically inexpensive strand exchange, is introduced by the recombinase itself concomitant with DNA binding and synapsis. Here, we show that this is not the case for XerH, which binds and assembles its recombination substrates in an almost straight conformation. The required DNA bending then presumably occurs upon activation by an external factor that is present only in a particular spatial and temporal context, providing an elegant regulatory mechanism to ensure faithful chromosome segregation.

Our modeling of XerC/D*-dif* indicates that the architectures of the pre- and post- cleavage synaptic complexes are probably conserved between XerC/D and XerH ([Figure 5B](#fig5){ref-type="fig"}). The DNA conformational changes that we observe for XerH-*dif~H~* are also consistent with smFRET studies of XerC/D-*dif* synaptic complexes ([@bib19]; [@bib71]), which imply a conformational change upon FtsK-mediated activation consistent with the differences between our models of the pre-cleavage and post-cleavage complexes. Thus, we expect that the mechanism of catalytic activation proposed here for XerH -- preassembly of a synaptic complex with almost straight DNA, followed by FtsK-induced protein and DNA rearrangements activating the complex for catalysis -- may be conserved in the XerC/D system.

In summary, our structures of XerH-*dif~H~* complexes demonstrate that catalysis by the Xer family of site-specific recombination systems follows the established tyrosine recombinase pathway, with the reaction steps being choreographed by small differences in the arms of the *dif* recombination sites. Contrary to previous assumption, bending of the *dif* sites does not occur concomitantly with synaptic complex assembly but at a post-synaptic step, when the accessory factor FtsK might be needed to license the reaction by promoting a conformational change. We also provide structural insight into the conformational change required for activation ([Video 1](#media1){ref-type="other"}), and extend our findings to other Xer recombinases through modeling. Our structural insights help us to better understand how Xer proteins function and how they have adapted the tyrosine recombinase machinery for their unique genome maintenance function. In the long term, our data can also help to improve XerH-based genetic engineering tools that have been recently introduced for markerless gene deletions in *H. pylori* ([@bib18]).

Materials and methods {#s4}
=====================

DNA constructs {#s4-1}
--------------

Full-length *xerH* from *H. pylori* strain 26995 (NCBI: HP0675) was synthesized with codon-optimization (MrGene, Regensburg, Germany) for over-expression in *E. coli* and cloned into vector pETM-28 (PepCore, EMBL) using BamHI/XhoI restriction sites. XerH Y344F, R213K, S161A, and K290S constructs were prepared by site-directed mutagenesis using primers listed in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"}.

Protein expression and purification {#s4-2}
-----------------------------------

*H. pylori* XerH and its mutants were overexpressed in *E. coli* BL21 (DE3) as N-terminal fusions with hexahistidine and Small Ubiquitin-like Modifier (SUMO) tags. The constructs were expressed in *E. coli* BL21 (DE3) for 16 h at 15°C after addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were lysed by sonication in purification buffer (1x phosphate buffered saline (PBS), 1 M NaCl, 5% glycerol, and 0.2 mM tris(2-carboxyethyl)phosphine (TCEP), pH 7.5) supplemented with protease inhibitors (cOmplete Protease Inhibitor Cocktail, Roche Diagnostics, Mannheim, Germany; 1.5 mM phenylmethanesulfonylfluoride \[PMSF\]). The lysate was cleared by centrifugation at 40,000 *g*. The protein was purified from the soluble fraction by Ni-affinity chromatography on a HisTrap column (GE Healthcare, Munich, Germany), followed by tag cleavage with SenP2 protease, tag removal on a Ni-affinity column, and size exclusion chromatography on Superdex 200 column (GE Heathcare). The seleno-methionine derivative of XerH was expressed in BL21 (DE3) in M9 growth medium supplemented with the essential amino acids, with seleno-methionine replacing methionine, and was purified as above.

DNase I footprinting {#s4-3}
--------------------

The XerH-*dif~H~* complexes were formed in activity buffer (25 mM HEPES, pH 7.5, 100 mM NaCl, 10 mM MgCl2, 5% glycerol, 1 mM DTT, and 1 mM EDTA). 120 bp substrates containing the left or right TnPZ end were PCR-amplified from *H. pylori* 26695 genomic DNA using 5'-^32^P-labelled primers shown in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"}. Samples were incubated with various amounts of DNase I for 1 min after addition of 5 mM CaCl~2~ and 10 mM MgCl~2~. The reactions were stopped with 120 mM NaCl, 18 mM EDTA, and 0.6% SDS, DNA was purified by ethanol precipitation and analyzed by PAGE on Urea-TBE 12% gel. Sequencing ladders were prepared with DNA Cycle Sequencing Kit (Jena Bioscience, Jena, Germany) using 5'-^32^P-labeled primers.

Crystallization and data collection {#s4-4}
-----------------------------------

DNA oligonucleotides were synthesized and HPLC-purified by IDT (Leuven, Belgium), then annealed in TE buffer by heating to 98°C and slow cooling to room temperature or 4°C. XerH-*dif~H~* complexes were formed by mixing XerH with DNA (sequences shown in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"}) at a 1.2:1 molar ratio in purification buffer, dialyzed in three steps to crystallization buffer containing 25 mM sodium acetate buffer (pH 5.5), 200 mM NaCl, 5% glycerol, and 1 mM DTT, and concentrated to 5 mg/ml. The crystallization conditions were screened using The Classics Suite (QIAGEN, Hilden, Germany), Index (Hampton Research, Aliso Viejo, CA, USA), and JCSG+ ([@bib52]) sparse matrix crystallization screens by sitting drop vapor diffusion. The resulting hits were scaled-up and optimized in hanging-drop vapor diffusion setup. 2 μl of complex solution were mixed with 2 μl of well solution and equilibrated against 0.5 ml well solution for two weeks at 6°C. The pre-cleavage complex was crystallized using well solutions containing 0.2 M NaCl and 20--25% (w/v) polyethylene glycol (PEG) 3350, while for the post-cleavage complex 0.1 M HEPES, pH 7--8, 0.2 M MgCl~2~, and 25--35% (v/v) PEG 400 was used. For data collection, the crystals were harvested and flash-frozen in liquid nitrogen. The pre-cleavage complex crystals were cryoprotected by the addition of 20% v/v glycerol. The data were collected on beamline ID-29 at the European Synchrotron Radiation Facility (ESRF) and on beamline I04-1 at the Diamond Light Source (DLS).

Structure determination {#s4-5}
-----------------------

The diffraction data were processed with XDS ([@bib34]). The structure of the post-cleavage complex was determined by SAD phasing in AutoSHARP ([@bib66]), using anomalous data from a seleno-methionine derivative crystal. The phases were extended onto a native dataset, and the initial model was built in AutoBuild in Phenix ([@bib1]; [@bib60]). The asymmetric unit contained two XerH molecules and one nicked *dif~H~*LP DNA, with two-fold crystallographic symmetry generating a tetramer.

The structure of the pre-cleavage complex was solved by molecular replacement in Phaser ([@bib47]), using an XerH monomer as a search model. This structure showed four XerH molecules and two *dif~H~* DNA per asymmetric unit. The final models were obtained by alternating model building in *Coot* ([@bib21]) and simulated annealing, restrained positional and B-factor refinement with Phenix ([@bib2]). The data collection and refinement statistics are given in [Table 1](#tbl1){ref-type="table"}. Protein interfaces were analyzed in PISA ([@bib39]), protein-DNA contacts in NUCPLOT ([@bib45]), and DNA topology in W3DNA ([@bib72]). All structural figures were made in PyMOL (Version 1.5.0.4; Schrödinger, LLC, New York, NY, USA) and animations in Chimera ([@bib54]).

Binding assays {#s4-6}
--------------

For electrophoretic mobility shift assays (EMSA), XerH was incubated with 50 bp *dif~H~* DNA or its derivatives ([Supplementary file 1](#SD3-data){ref-type="supplementary-material"}) in the activity buffer as for DNase I footprinting for 1 h at 30°C. 20 nM 5'-^32^P-labelled DNA was titrated with increasing amounts of XerH (0--360 nM), and complex formation was assessed on native 12% polyacrylamide TBE gels. Gels were imaged in a Typhoon FLA 7000 Phosphoimager, and images were quantified and analyzed with ImageQuant (GE Healthcare). Dissociation constants (K~D~) were calculated for the sum of all complex species. XerH-*dif~H~* complexes were also analyzed by analytical size exclusion chromatography on Superdex 200 3.2/30 column on Äkta systems (GE Healthcare). The XerH-DNA complexes were prepared as for crystallization.

In vitro activity assays {#s4-7}
------------------------

Cleavage assays were carried out in activity buffer with 25 μM XerH and 25 μM *dif~H~* substrates. 'Suicide' *dif~H~* substrates containing nicks in the backbone of both DNA strands 1 nt 3' to the cleavage position were used. These substrates trap the covalent XerH-*dif~H~* reaction intermediates ([Figure 3C](#fig3){ref-type="fig"}) as seen for Cre recombinase and λ integrase ([@bib28]; [@bib53]). Oligonucleotide sequences are shown in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"}. DNA substrates were annealed by slow cooling from 98°C to 4°C. The reactions were incubated for 1 h at 37°C, and analyzed by SDS-PAGE.

Recombination assay {#s4-8}
-------------------

XerH-mediated intramolecular recombination was assessed in *E. coli* by a *galK* marker-based assay, similar to the one described by ([@bib4]). The *dif~H~* cassette was PCR-amplified from *H. pylori* 26695 genome using primers shown in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"} and inserted in a direct repeat orientation at two positions of plasmid pMS183Δ using NheI/BsrGI or EcoRI/KpnI restriction sites. The mutated variants of the *dif~H~* cassette were obtained by site-directed mutagenesis of the constructed plasmids using primers shown in [Supplementary file 1](#SD3-data){ref-type="supplementary-material"}. The *xerH* gene was cloned from the expression plasmids used for XerH production into plasmid pBAD/MCS (PepCore, EMBL) using NcoI/XhoI restriction sites. GalK-deficient *E. coli* strain DS941 was sequentially transformed first with the XerH expression plasmid, and then with the reporter plasmid. Transformants were plated on 4% (w/v) MacConkey agar (Difco^TM^, Becton and Dickinson, Heidelberg, Germany) supplemented with 1% (w/v) galactose, 50 μg/ml kanamycin, and 100 μg/ml ampicillin. Upon XerH expression, recombination between the two *dif~H~* sites leads to loss of *galK.* After overnight growth the plates were scraped to resuspend the cells in 1 ml of LB, and an overnight culture was set up with 1 μl of the scraped cells. *E. coli* DS941 cells were transformed with the plasmid DNA extracted from the overnight cultures, and the cells were plated again on MacConkey agar supplemented with 1% (w/v) galactose and 50 μg/ml kanamycin. Red (indicating no recombination) and white (indicating recombination deleting the *galK* gene from the plasmid) colonies were counted and recombination efficiency was calculated as the number of white colonies divided by the total number of colonies. Representative plasmids from white colonies were analyzed by agarose gel electrophoresis and sequencing to confirm that reciprocal recombination between *dif~H~* sites had occurred as predicted.

Modeling of XerC/D-*dif* complexes {#s4-9}
----------------------------------

First, DNA-bound XerC and XerD were modeled using the DNA-free XerD structure (PDB: 1 A0P) ([@bib59]) and an XerC homology model created using I-TASSER ([@bib67]). XerC/D tetramers were assembled by superposing individual protein domains onto our XerH-*dif~H~* structures by rigid structural alignment using FATCAT ([@bib44]) with XerD placed onto the left *dif~H~* arm (i.e. superposed onto subunit A in the cleavage-competent conformation). Flexible parts that could not be aligned (αM-αO and β2-β3 hairpin) were isolated and modeled by threading with Phyre2 ([@bib35]; [@bib37]). *dif* DNA was modeled with mode-RNA server ([@bib56]) using *dif~H~* as a template and refined in HADDOCK ([@bib65]). Both pre- and post-cleavage complexes were modeled and the assembled models were refined in HADDOCK to optimize molecular geometry.

Database accession codes {#s4-10}
------------------------

Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 5JK0 (XerH-*dif~H~* pre-cleavage synaptic complex) and 5JJV (XerH-*dif~H~*LP post-cleavage synaptic complex).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Structural snapshots of Xer recombination reveal activation by synaptic complex remodeling and DNA bending.\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and John Kuriyan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Gregory D Van Duyne.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Understanding the mechanism of Xer recombination at chromosomal dif sites is acknowledged to be a long-standing, challenging problem. In this regard, the manuscript provides an extensive structural and biochemical analysis of the Helicobacter Xer-dif recombination machine in a well-written and well-documented manner, and that it reveals new details of the steps involved in this important reaction. Showing for the first time high resolution structures of a Xer recombinase complexed with DNA and these structures was unanimously considered to be useful for modelling and understanding other Xer recombinases.

This said, there was some debate as to the novelty and impact of the insights they propose. One reviewer felt that the model in which inactive, un-bent synaptic Xer/dif complexes form and are then induced to bend and cleave by FtsK is intriguing and would constitute a major advance in understanding Xer/dif recombination (if correct). Another reviewer mentioned that the structures of the pre-cleavage (and catalytically inactive) and post-cleavage (on a nicked \'suicide\' substrate) synaptic complexes are important and provide some surprises, but that their mechanistic significance is more incremental, with the final model (at least as depicted) adding little to what has been published previously.

In going forward, attention should be paid to depicting and improving the discussion of what new insights can gained from the present work to resolve this debate -- i.e., how specifically do the structural snapshots and associated biochemistry inform or change the field\'s understanding of Xer recombination mechanism in a meaningful way? In addition, there are several other issues that need to be addressed before a final decision can be reached. These include:

1\) The paper overreaches in trying to reinforce the biological significance of the work. In the Abstract for example, the statement that the work will \"open up new avenues towards the antibacterial treatment\" is far-fetched. The same applies to the statement (in the Abstract and elsewhere) that the work provides mechanistic insight into the action of FtsK in stimulating the reaction. Similar overreach is present in the Discussion. In general, statements relating to how FtsK activates Helicobacter Xer recombination or how the present study will aid drug discovery should be downplayed, as there are no direct experiments or data that relate to these points. Relevant to the FtsK, would it be appropriate to bring up and cite the subsequent Zawadzki work (May et al. 2015) on FtsK activation as monitored in single-molecule FRET.

2\) [Figure 3E](#fig3){ref-type="fig"}. Was the Xer recombination observed in *E. coli* FtsK-dependent ([Figure 3E](#fig3){ref-type="fig"} and supporting information)? If the authors still wish to focus on the importance of FtsK in activating Xer recombination, this is an important experiment. If it is FtsK-dependent, is this expected given the differences between Helicobacter FtsK and *E. coli* FtsK (and would one expect Helicobacter Xer to be acted on by *E. coli* FtsK, if indeed this is the case?). Some comment on this question is needed.

3\) In [Figure 6](#fig6){ref-type="fig"} and the associated text, there is a problem with the proposal that the binding of the two recombinases to dif is temporally sequential in a mechanistic sense. How can this be? The observed affinities for the two dif arms are presumably determined by the relative off-rates, meaning that the left site is more often occupied than the right site, and leading to the second molecule binding to the right site more often than vice versa. Why not simply restate this way? Along these lines, a substantial part of [Figure 6](#fig6){ref-type="fig"} is a repeat of what is in [Figure 1](#fig1){ref-type="fig"}. It is suggested that [Figure 6](#fig6){ref-type="fig"} be deleted and that relevant new panels be incorporated into [Figure 5](#fig5){ref-type="fig"}.

4\) The evidence that XerH does not cleave linear dif sites shown in supplemental [Figure 6](#fig6){ref-type="fig"} seems weak. *E. coli* XerCD can cleave dif sites in vitro and in vivo in the absence of FtsK, but this cleavage is non-productive (XerC generates and resolves HJs or cleaves and re-ligates; XerD is inactive). By analogy, XerH bound to the left half-site of dif resembles XerC in its properties (i.e., the more active half). The authors have made the opposite assignment in their model of XerC/XerD/dif shown in [Figure 5](#fig5){ref-type="fig"}, which is consistent with current views that XerD catalyzes the first strand exchange when activated by FtsK. However, this assignment implicitly assigns XerD half to be the more active one, based on the data presented. The synaptic complex structure determined in this work might instead correspond to the alternative \'XerC cleavage\' synaptic complex: the one that undergoes futile cycling. The reaction schematic shown in [Figure 6](#fig6){ref-type="fig"} implies that the more reactive dif half-sites initiate strand exchange (with the help of FtsK) and the inactive half-sites resolve the HJ intermediate, based on the structural models and biochemistry presented. This is the opposite of the currently favored mechanism for *E. coli* Xer/dif recombination. Please comment on this point.

5\) The cleaved complex confirms that Xer enzymes proceed through a Cre-like pathway once activated, with sharply bend DNA arms, etc. Unfortunately, the structure has been symmetrized to be Cre-like, possibly masking asymmetric features that may be present. In particular, it may be difficult to conclude much from the inter-subunit interactions present, since the asymmetries introduced by the right half-site have been lost. This point should be noted in the text.

6\) The pre-cleavage complex was crystallized without divalent ions, at pH 5.5. The post-cleavage complex was crystallized at pH 7 in the presence of a high concentration of divalent ions. An alternative interpretation of the current results is that the observed structures reflect the crystallization conditions and that the synaptic complex is actually bent (to some extent) at netural pH with Mg^2+^ present. The authors should address this alternative explanation in the paper.

7\) The cooperativity of XerH binding to dif is actually very low, given the similar half-site vs. full site binding constants. The wording in the manuscript is somewhat misleading in this respect -- it is surprising how low the cooperativity is, given the extent of inter-subunit interactions on a single dif site. The authors should report what this interaction surface is and discuss the lack of strong cooperative binding in light of the structure.

8\) It would be useful to report whether a bent, but un-nicked duplex substrate can be reconstructed (modeled) from the cleaved complex. This would indicate whether the higher energy bent form of dif is likely to resemble the cleaved configuration, or alternatively, whether the cleaved complex undergoes additional bending and subunit rotations that occur after cleavage has occurred.

9\) The authors suggest that the suicide substrates used are cleaved by XerH because the nicks facilitate the required bend. Usually, the energetic cost of DNA bending is mostly related to unstacking of the bases, which nicking does not solve. Do the current structures explain how the nicks might be specifically allowing higher cleavage for this system -- e.g., through relieving a strained backbone configuration? Or are they simply allowing the cleavage product to accumulate? Is the structure of an XerH catalytic mutant bound to nicked dif sites expected to be bent?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Structural snapshots of Xer recombination reveal activation by synaptic complex remodeling and DNA bending\" for further consideration at *eLife*. Your revised article has been favorably evaluated by John Kuriyan (Senior editor), a Reviewing editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below. Note that these issues can all be dealt with through textual changes, and do not require any additional experiments.

1\) The models in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [6](#fig6){ref-type="fig"} cause some confusion as to how the structures might be interpreted in light of the XerH mechanism. Please consistently draft these figures with the strand going from 5\' \[on the left\] to 3\' \[on the right\] placed on \'top\' in each of the views \[i.e. viewing from the minor groove side in each case\]. The authors should also acknowledge that an alternative model is consistent with their data in which FtsK is required to make the alternative synaptic complex and/or explain why such a model isn\'t favored.

2\) Subsection "Modeling of *E. coli* XerC/D synaptic complex based on the XerH-difH structures". In the absence of supporting data indicating that XerH will preferentially resolve HJs by bottom strand exchange, this claim should be removed. See also Discussion paragraph 7 in reference to this point.

3\) Discussion section, paragraph one. Aside from the crystal structure reported here, there is other evidence that XerH/dif sites are assembled in an inactive synaptic complex in solution (e.g., Zawadzki et al. should be noted). Is there additional evidence for XerH/difH?

4\) Authors\' response \#1 and related manuscript sections. What is the evidence that XerH does not cleave dif sites in vitro? This has been a tricky issue in the field, since it is hard to distinguish cleavage followed by rapid ligation from lack of cleavage. Unless the authors can provide data (e.g., using 5\'-bridging phosphorothiolates) that demonstrate lack of cleavage, it would be better to take the position that it is not yet clear whether cleavage occurs in vitro. It is also difficult to explain activity in *E. coli* with such a model. In contrast, the behavior is readily explained if XerH bound to the left end behaves like XerC (as in an alternative model). Related to this is the question of whether cleavage is required for stabilization of the synaptic complex, independent of FtsK. This is true of λ int and several catalytic Cre mutants form much weaker synaptic complexes relative to wild-type Cre, suggesting that this could also be true in XerH as well. The nicked XerH/DNA complex also supports this idea. Thus, the synaptic complex structure observed for XerH could equally well represent a stable intermediate that can reach the transient bent configuration required for cleavage on its own. Please resolve/comment on this issue.

5\) Authors\' response \#6. The reviewers requested that the authors note the possibility that the synaptic complex structure may be influenced by crystallization conditions (low pH and/or lack of divalents). The authors acknowledge this in their response to reviewers, but do not appear to have modified the manuscript. Given that this structure is central to the authors\' proposals for Xer recombination, the readers should be made aware that the conditions for the two structures are quite different. Please revise the manuscript accordingly.

6\) The authors note that several unbound Xer crystal structures show different domain relationships, but continue to promote the idea that a specific conformational change takes place upon DNA binding (as shown in the video). To echo the original review, it is unlikely that the XerD alone structure represents a true \"conformational intermediate,\" rather than just one of an ensemble of configurations present when Xer subunits are not bound to dif. The three Xer crystal structures in the PDB have their NTDs in completely different conformations. The ideas in the discussion and video illustrating that the NTD has to undergo a significant change when completing the clamp on the dif half-site was assumed many years ago by most people in the field and is true for all tyrosine recombinases. This point should clarified or else its discussion (and the movie) should be removed from the paper.

7\) The distinction between understanding the mechanism of recombination vs. regulation of this process is important, but not made clear (Abstract and Introduction sections). The authors imply that the mechanism of XerC/XerD recombination is still unknown.

8\) Introduction paragraph six. The structures do not delineate the pathway (delete this) but do shed light on potential regulatory mechanisms (reword).

9\) In the same section the structure does not explain why activation is required. It suggests a possible model, as described by the authors, which differs from at least one other XerCD model.

10\) Results paragraph one. The current mechanism is based on much more than the series of Cre-loxP structures cited. A review covering tyrosine recombinase mechanisms (there are many) might be more appropriate here.

11\) Subsection "Structure of the XerH-difH synaptic complex" need to be redrafted to accurately to describe the historical record (in doing so, the authors should consider point 9 and earlier comments regarding alternative models). The current text is incomplete and in part misleading. In the absence of FtsK, HJs formed by XerC were detected in early work and this led to the hypothesis that the XerC active conformation formed preferentially and FtsK switched the conformation of an XerC active complex to one in which XerD was active. Single-molecule FRET experiments by Zawadzki and colleagues led to the different hypothesis that this is not the case; rather, the major synaptic complex that forms in the absence of FtsK is an \'XerD potentially active conformation,\' which is catalytically dead. A small proportion of XerC active complexes nevertheless form and are responsible for the XerC HJs. Nevertheless, the dominant pre-active XerD synaptic complexes are the ones activated by XerD. This is consistent with the results here, but the historical development of these ideas should be explicitly chronicled.

12\) Subsection "Structure of the XerH-difH synaptic complex" paragraph two. DNA duplex, not oligonucleotide.

10.7554/eLife.19706.028

Author response

\[...\] In going forward, attention should be paid to depicting and improving the discussion of what new insights can gained from the present work to resolve this debate -- i.e., how specifically do the structural snapshots and associated biochemistry inform or change the field\'s understanding of Xer recombination mechanism in a meaningful way? In addition, there are several other issues that need to be addressed before a final decision can be reached.

We hope that our revisions have added clarity with respect to the novelty of our study. We have now included a paragraph at the beginning of Discussion to summarize the novel data and insights brought about by our work. We have also modified the text throughout, particularly the final paragraph of the discussion, to better emphasize the impact of our results for understanding of Xer recombination and tyrosine recombination more generally.

The main novel aspects of our study and their impact are summarized below for your information:

We report the first high-resolution structures of an Xer recombinase in synaptic complex with its DNA substrates. Such a structure has been long sought, as its absence prevented proper understanding of this important family of site-specific recombination systems. Structural models relying on available structures of the Cre/lox system and others left several questions unanswered. Especially with regard to the molecular mechanism of Xer activation at chromosomal dif sites, it remained unclear why Xer proteins require activation in the first place, and what the molecular assemblies and rearrangements preceding activation might look like (all previous tyrosine recombinase-DNA structures reflected macromolecular assemblies highly similar to the activated state). In this manuscript, we present two structures of the XerH-difH synaptic complex captured at distinct stages of the recombination reaction, which shed light on critical steps of the reaction, and the structural changes involved in XerH activation.

Our wild-type XerH-difH synaptic complex structure reveals a cleavage-incompetent conformation with almost straight DNA that has never been observed for tyrosine recombinases before. This structure shows that conformational changes are required for recombination activation, and suggests that an external factor may be required to facilitate the transition. Based on published evidence that XerH recombination requires FtsK in H. pylori (Debowski et al., 2012) and by analogy with the XerC/D system, it seems reasonable to predict that the need for this conformational change may be key to the regulation of Xer proteins, and that FtsK may be directly involved in facilitating this transition. While this model requires further validation, our structure will help to create testable experimental hypotheses.

We also present a post-cleavage XerH-difH synaptic complex structure (trapped using nicked suicide DNA substrates). This structure resembles previously reported post-cleavage structures of other tyrosine recombinases with strongly bent DNA, confirming that the chemistry of catalysis by Xer proteins likely resembles canonical tyrosine recombination. Comparison of our pre- and post-cleavage structures also illustrates the structural rearrangements required for activation of Xer recombination. Unexpectedly, these changes include a major rearrangement of the intermolecular protein interfaces and significant DNA bending. This is consistent with previously published smFRET data (Zawadzki et al., 2013, see below), and supports the idea that pre-formed Xer recombinase synaptic complexes can be remodeled without energetically inefficient disassembly and reassembly of the complex.

Our structures also show that strong DNA bending is not necessarily concomitant with synaptic complex assembly in tyrosine recombination, at least for the XerH-difH system.

Our structural and biochemical data reveal how a small asymmetry in the *dif~H~* site helps to establish correct ordering of strand cleavages and ligations in recombination by the homomeric Xer recombinase XerH.

Modeling extends our data to the prototypical XerC/D system, indicating that the XerH-*dif~H~* structures provide a useful resource for understanding other Xer recombinases.

*1) The paper overreaches in trying to reinforce the biological significance of the work. In the Abstract for example, the statement that the work will \"open up new avenues towards the antibacterial treatment\" is far-fetched. The same applies to the statement (in the Abstract and elsewhere) that the work provides mechanistic insight into the action of FtsK in stimulating the reaction. Similar overreach is present in the Discussion. In general, statements relating to how FtsK activates Helicobacter Xer recombination or how the present study will aid drug discovery should be downplayed, as there are no direct experiments or data that relate to these points. Relevant to the FtsK, would it be appropriate to bring up and cite the subsequent Zawadzki work (May et al. 2015) on FtsK activation as monitored in single-molecule FRET.*

In accord with the comments of the reviewers, we have removed all the comments regarding the potential use of our structures for antibiotic discovery. We have also rephrased the text referring to FtsK activation of Xer recombination, to clarify how far our data go and where hypothesis starts.

We do however maintain that our structural and biochemical data provide some important insights into the activation of XerH recombination by FtsK. First, our observations that wild-type XerH-*dif~H~* synaptic complexes assemble in a cleavage-incompetent conformation and that XerH alone is unable to cleave wild-type DNA substrates in vitro indicates that the help of an external factor is needed for activation. In agreement with this idea, literature evidence from Debowski et al., 2012 showed that XerH recombination is critically dependent on FtsK in *H. pylori*, and strains lacking the C-terminal part of FtsK show a strong filamentous phenotype and no detectable XerH-*dif~H~* recombination. Therefore, it seems reasonable to presume that FtsK activates XerH in vivo in *H. pylori,* as *E. coli* FtsK activates XerC/D-*dif* recombination in *E. coli.* Second, comparison of the inactive XerH-*dif~H~* pre-cleavage complex with our activated post-cleavage complex structure indicates that XerH activation involves large conformational changes in pre-formed synaptic complexes. This is also in line with smFRET data reported by Zawadzki et al., 2013 and Diagne et al., 2014 for XerC/D-*dif* complexes.

Thus, we predict that FtsK is directly involved in activating XerH in *H. pylori*, probably via facilitating the conformational changes observed in our structures. Nevertheless, we acknowledge that our data do not provide clear-cut evidence for the exact function of FtsK, and do not address exactly how FtsK acts on the molecular or structural level. Insights into these questions will require further investigations, and we have now clarified this further in the manuscript (Discussion section).

Reference to May et al., 2015 has been added (Introduction section).

*2) [Figure 3E](#fig3){ref-type="fig"}. Was the Xer recombination observed in E. coli FtsK-dependent ([Figure 3E](#fig3){ref-type="fig"} and supporting information)? If the authors still wish to focus on the importance of FtsK in activating Xer recombination, this is an important experiment. If it is FtsK-dependent, is this expected given the differences between Helicobacter FtsK and E. coli FtsK (and would one expect Helicobacter Xer to be acted on by E. coli FtsK, if indeed this is the case?). Some comment on this question is needed.*

The experiment shown in [Figure 3E](#fig3){ref-type="fig"} used a standard *E. coli* lab strain with wild type FtsK. To check if XerH-*dif~H~* recombination was dependent on *E. coli* FtsK in this assay, we tested recombination in the *E. coli* strain DS9041, which lacks the C-terminal part of FtsK (FtsK-C) (kindly provided by Prof. Dave Sherratt). Note that full deletion of FtsK is lethal and cannot be used in these assays, but FtsK-C deletion was previously shown to be sufficient to abolish XerC/D activation (*Recchia et al., 1999; Steiner et al., 1999*). Plasmid-based intramolecular XerH-*dif~H~* recombination assays in this strain showed similar levels of *dif~H~*-galK-*dif~H~* cassette excision as was observed in the wild-type strain, suggesting that deletion of FtsK-C does not affect this reaction.

Chromosome resolution by XerH-*dif~H~* recombination in its native *H. pylori* is known to require FtsK (*Debowski et al., 2012*). So, to check if chromosome dimer resolution by XerH-*dif~H~* recombination can occur in *E. coli*, we replaced the *dif* site of the *E. coli* chromosome with *dif~H~*-Km and supplemented this strain with an XerH expression plasmid. This showed a phenotype consistent with loss of chromosome dimer resolution (\~10% of elongated *E. coli* cells that are unable to divide), irrespective of the presence or absence of *E. coli* FtsK-C. This showed that XerH-*dif~H~* recombination on chromosomes is compromised in *E. coli*, and *E. coli* FtsK cannot fully complement for the function of *H. pylori* FtsK. These results are consistent with previous reports showing that the Xer-FtsK interactions can be species-specific (*Yates et al. 2003*).

The fact that we still observe detectable levels of intramolecular XerH-*dif~H~* recombination on plasmid-borne *dif~H~*-galK-*dif~H~* cassettes in *E. coli* may be due to the high sensitivity of this assay (using a protein overexpression plasmid and multi-copy reporter plasmids), or it may indicate that factors other than *E. coli* FtsK-C (e.g. DNA bending by supercoiling, or other *E. coli* proteins) can activate XerH in this setting. However, elucidating the exact function of *H. pylori* FtsK and the effects of other interaction partners on XerH recombination requires further investigations, which are beyond the scope of the current study.

*3) In [Figure 6](#fig6){ref-type="fig"} and the associated text, there is a problem with the proposal that the binding of the two recombinases to dif is temporally sequential in a mechanistic sense. How can this be? The observed affinities for the two dif arms are presumably determined by the relative off-rates, meaning that the left site is more often occupied than the right site, and leading to the second molecule binding to the right site more often than vice versa. Why not simply restate this way?*

We agree with the reviewer on this point. We have rephrased the corresponding text (Discussion section) and figure legend as requested, and avoid using the term 'sequential binding' throughout.

*Along these lines, a substantial part of [Figure 6](#fig6){ref-type="fig"} is a repeat of what is in [Figure 1](#fig1){ref-type="fig"}. It is suggested that [Figure 6](#fig6){ref-type="fig"} be deleted and that relevant new panels be incorporated into [Figure 5](#fig5){ref-type="fig"}.*

We agree that [Figure 6](#fig6){ref-type="fig"} was unnecessarily repetitive. We have now removed panels E-G and keep only the parts that are needed to illustrate the model we propose for XerH recombination. For the benefit of the broad readership of *eLife*, however, we prefer to keep this model figure separate from the other data figures.

*4) The evidence that XerH does not cleave linear dif sites shown in supplemental [Figure 6](#fig6){ref-type="fig"} seems weak. E. coli XerCD can cleave dif sites* in vitro *and* in vivo *in the absence of FtsK, but this cleavage is non-productive (XerC generates and resolves HJs or cleaves and re-ligates; XerD is inactive). By analogy, XerH bound to the left half-site of dif resembles XerC in its properties (i.e., the more active half). The authors have made the opposite assignment in their model of XerC/XerD/dif shown in [Figure 5](#fig5){ref-type="fig"}, which is consistent with current views that XerD catalyzes the first strand exchange when activated by FtsK. However, this assignment implicitly assigns XerD half to be the more active one, based on the data presented. The synaptic complex structure determined in this work might instead correspond to the alternative \'XerC cleavage\' synaptic complex: the one that undergoes futile cycling. The reaction schematic shown in [Figure 6](#fig6){ref-type="fig"} implies that the more reactive dif half-sites initiate strand exchange (with the help of FtsK) and the inactive half-sites resolve the HJ intermediate, based on the structural models and biochemistry presented. This is the opposite of the currently favored mechanism for E. coli Xer/dif recombination. Please comment on this point.*

We agree with the referee that assignment of XerC and XerD to the individual XerH subunits in our XerH-*dif~H~* synaptic complexes is ambiguous. Our XerH cleavage experiments might indeed be reporting on 'futile cycling' by the subunit bound at the left arm and we cannot fully exclude the possibility that our structures reflect a 'futile cycling' state. However, we note that currently there is no evidence that XerH is subject to the same 'futile cycling' mechanism as the XerC/D-*dif* system. (In fact, XerC/D itself is also not subject to this phenomenon when acting on plasmid-borne *cer* and *psi* sites.) Instead, our results indicate that while first XerH cleavage preferentially occurs on the left arm, resolution of a Holliday Junction substrate (mentioned in the Discussion section as "data not shown") occurs by cleavage of the right *dif~H~* arm. Drawing analogy with the XerC/D-*dif* system, this observation would map XerC to the XerH subunit bound to the right arm (because it is XerC that resolves preformed HJ substrates with or without FtsK), and thus XerD to the left arm-bound subunit. This, together with the observed lack of cleavage on native (un-nicked) substrates ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), indicates that XerH might not be affected by futile cycling. Instead, XerH synaptic complexes appear to assemble directly in the correct configuration, but normally remain inactive in the absence of FtsK. Introduction of nicks in the DNA substrates might mimic the effect of FtsK, allowing activation of left arm cleavage as seen in our cleavage assays and the post-cleavage structure.

We now state this ambiguity and explain our choice for XerC/D assignment (subsection "Modeling of E. coli XerC/D synaptic complex based on the XerH-difH structures").

*5) The cleaved complex confirms that Xer enzymes proceed through a Cre-like pathway once activated, with sharply bend DNA arms, etc. Unfortunately, the structure has been symmetrized to be Cre-like, possibly masking asymmetric features that may be present. In particular, it may be difficult to conclude much from the inter-subunit interactions present, since the asymmetries introduced by the right half-site have been lost. This point should be noted in the text.*

We appreciate that our synaptic complex with symmetrized *dif~H~*LP might not fully reflect the subunit arrangement and interactions in the native XerH-*dif~H~* complex. However, we note that the overall structure of each XerH subunit and their interactions with the respective *dif~H~* DNA arms in the XerH-*dif~H~*LP complex and the XerH -- native *dif~H~* (pre-cleavage) complex are very similar (see subsection "Conformational rearrangements in the post-cleavage synaptic complex"), suggesting that substrate symmetrization does not have a profound effect on the synaptic complex structure. We note that crystal structures of Cre/lox synaptic complexes also showed highly similar arrangements with symmetrized and native substrates (Guo et al. 1997, Guo et al. 1999, Ennifar et al. 2003). Moreover, we would like to emphasize that -- despite the use of symmetrized substrates -- the conformations of the two XerH subunits bound to the two arms of one difHLP site are quite different and the XerH-difHLP structure is actually 'asymmetric' in this sense (i.e. the complex has only dyad symmetry connecting the two difH sites across the synaptic interface; there is no symmetry connecting the protein molecules bound to two halves of one difHLP site). Since we observe very similar 'asymmetry' in the native pre-cleavage XerH-difH complex, this feature appears to be intrinsic to the natural system. We have now revised the text (last paragraph in subsection "Conformational rearrangements in the post-cleavage synaptic complex") to make this clearer.

*6) The pre-cleavage complex was crystallized without divalent ions, at pH 5.5. The post-cleavage complex was crystallized at pH 7 in the presence of a high concentration of divalent ions. An alternative interpretation of the current results is that the observed structures reflect the crystallization conditions and that the synaptic complex is actually bent (to some extent) at netural pH with Mg^2+^ present. The authors should address this alternative explanation in the paper.*

We acknowledge that the crystallization conditions may have an influence. However, we have tested XerH activity under the exact crystallization condition used for the pre-cleavage complex (pH 5.5, no metal ions) and observe a good level of DNA cleavage with nicked DNA substrates, indicating that the crystallization conditions are not primarily responsible for the inactive conformational state we observe in our structure. In the Cre/*lox* system, both pre- and post-cleavage synaptic complexes invariably show a similar DNA bend and inter-subunit arrangement, irrespective of the crystallization conditions which included pH of 5 -- 7.6 and various divalent ion (Mg^2+^ or Ca^2+)^ concentrations.

*7) The cooperativity of XerH binding to dif is actually very low, given the similar half-site vs. full site binding constants. The wording in the manuscript is somewhat misleading in this respect -- it is surprising how low the cooperativity is, given the extent of inter-subunit interactions on a single dif site. The authors should report what this interaction surface is and discuss the lack of strong cooperative binding in light of the structure.*

All binding constants mentioned in the manuscript were measured with full-length DNA substrates; the substrates *dif~H~*L and *dif~H~*R contained random DNA sequence in place of the second *dif~H~* arm. Since these substrates can still bind two XerH subunits ([Figure 3 ---figure supplement 1B-D](#fig3s1){ref-type="fig"}) and all complex species were pooled for K~D~ calculations, the reported values do not reflect true 'half-site' binding constants. We apologize for this confusion, and have now revised the manuscript text to make this clear (subsection "difH asymmetry dictates the order of binding and cleavage events").

To evaluate cooperativity, we have prepared Hill plots based on our EMSA data, by plotting the logarithm of the fractional binding of the DNA substrate, against the logarithm of the protein concentration. This gave a high value for cooperativity, in agreement with the very sharp transition of all unbound DNA to all bound (in dimeric complex) observed on our EMSA gels with native *dif~H~* ([Figure 3 ---figure supplement 1A](#fig3s1){ref-type="fig"}). Similarly, high cooperativity was observed for XerC/D -- *dif* binding (e.g. Cao et al., 1997 and Spiers and Sherratt, 1997), and is consistent with the extensive inter-subunit interactions observed in our structures (now reported in Discussion section paragraph four), as also pointed out by the referees. However, we are aware that the exact level of cooperativity cannot be evaluated from our data and have rephrased the corresponding sections in the text.

*8) It would be useful to report whether a bent, but un-nicked duplex substrate can be reconstructed (modeled) from the cleaved complex. This would indicate whether the higher energy bent form of dif is likely to resemble the cleaved configuration, or alternatively, whether the cleaved complex undergoes additional bending and subunit rotations that occur after cleavage has occurred.*

We have performed the modeling as recommended, and find that the broken DNA strand can be joined in the cleaved complex structure with acceptable geometry, to reconstruct a bent but un-nicked substrate. However, the modeled DNA strand clashes with the protein in a loop region just before helix αN. This is now stated in the manuscript (paragraph two subsection "Conformational rearrangements in the post-cleavage synaptic complex"). This observation suggests that the protein might block proper bending of intact DNA, and changes in its conformation may be required to enable full DNA bending. Since the affected protein segment is closely connected to the catalytic tyrosine (on helix αN), its movement -- perhaps facilitated by interactions with FtsK -- may even explain the direct link between DNA bending and catalytic activation. Alternatively, cleavage might occur on partially bent DNA substrates, with additional bending occurring after cleavage. Interestingly, with the nicked substrates, the clash can be avoided thanks to the missing phosphate groups (see also our response to point 9).

While these hypotheses are intriguing, further experiments are required to evaluate the actual order of DNA bending and cleavage events.

*9) The authors suggest that the suicide substrates used are cleaved by XerH because the nicks facilitate the required bend. Usually, the energetic cost of DNA bending is mostly related to unstacking of the bases, which nicking does not solve. Do the current structures explain how the nicks might be specifically allowing higher cleavage for this system -- e.g., through relieving a strained backbone configuration? Or are they simply allowing the cleavage product to accumulate? Is the structure of an XerH catalytic mutant bound to nicked dif sites expected to be bent?*

Modeling of a putative bent, but un-cleaved XerH-*dif~H~* complex (based on the post-cleavage complex structure as described in point 8) indicated that the DNA might have somewhat strained backbone geometry, and the DNA appears to clash with the protein at the phosphate group exactly one nucleotide downstream of the scissile phosphate. Thus, we believe that the nicks favor the bent DNA conformation (paragraph two subsection "Conformational rearrangements in the post-cleavage synaptic complex") by helping to increase the flexibility of the DNA strands at the bending points and relieving the strained backbone conformation, and they may also help avoid unfavourable interactions with the protein upon DNA bending due to the absence of the phosphate implicated in the clash. Accordingly, we would expect a catalytic mutant XerH to bind to nicked *dif~H~* substrate roughly in the same conformation as the wild type protein, with a sharp DNA bend.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*\[...\] 1) The models in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [6](#fig6){ref-type="fig"} cause some confusion as to how the structures might be interpreted in light of the XerH mechanism. Please consistently draft these figures with the strand going from 5\' \[on the left\] to 3\' \[on the right\] placed on \'top\' in each of the views \[i.e. viewing from the minor groove side in each case\]. The authors should also acknowledge that an alternative model is consistent with their data in which FtsK is required to make the alternative synaptic complex and/or explain why such a model isn\'t favored.*

We appreciate this comment and understand the reviewers' concern regarding our drawings. Unfortunately, presenting the structures with viewing from the minor groove side would obscure visibility of important features of the structures (such as the DNA and the swapped C-terminal helix). Moreover, to conform with the previously published nomenclature of the *difH* arms we prefer to keep the 'left arm' on the left and the 'right arm' on the right side in our figures. This means that the schematic models in [Figures 1](#fig1){ref-type="fig"} and [6](#fig6){ref-type="fig"} should be drawn with the strand going 3' to 5' on the top to be consistent with the structure figures. However, to address the reviewers' concern and avoid confusion, we have now inverted the representation of the DNA sequence in [Figure 2A](#fig2){ref-type="fig"} (as well as in [Figure 4A](#fig4){ref-type="fig"} and in the figure supplements) so that it is now consistent with all other figures. In addition, we have clearly labeled both 5' and 3' ends of both strands on all DNA molecules in all drawings (see [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [6](#fig6){ref-type="fig"}), and state the directionality of the DNA in the corresponding legends.

Concerning the possible alternative model for the role of FtsK, this possibility is now mentioned and discussed in the manuscript ([Discussion section paragraph five]{.ul}).

*2) Subsection "Modeling of E. coli XerC/D synaptic complex based on the XerH-difH structures". In the absence of supporting data indicating that XerH will preferentially resolve HJs by bottom strand exchange, this claim should be removed. See also Discussion paragraph 7 in reference to this point.*

All claims referring to HJ resolution by XerH have now been removed from the manuscript as requested.

*3) Discussion section, paragraph one. Aside from the crystal structure reported here, there is other evidence that XerH/dif sites are assembled in an inactive synaptic complex in solution (e.g., Zawadzki et al. should be noted). Is there additional evidence for XerH/difH?*

This point has now been noted in the text. For the XerH/difH system in particular, apart from our structural and biochemical data, we are not aware of any additional literature evidence showing that synaptic complexes initially assemble in an inactive conformation.

*4) Authors\' response \#1 and related manuscript sections. What is the evidence that XerH does not cleave dif sites* in vitro*? This has been a tricky issue in the field, since it is hard to distinguish cleavage followed by rapid ligation from lack of cleavage. Unless the authors can provide data (e.g., using 5\'-bridging phosphorothiolates) that demonstrate lack of cleavage, it would be better to take the position that it is not yet clear whether cleavage occurs* in vitro*. It is also difficult to explain activity in E. coli with such a model. In contrast, the behavior is readily explained if XerH bound to the left end behaves like XerC (as in an alternative model). Related to this is the question of whether cleavage is required for stabilization of the synaptic complex, independent of FtsK. This is true of λ int and several catalytic Cre mutants form much weaker synaptic complexes relative to wild-type Cre, suggesting that this could also be true in XerH as well. The nicked XerH/DNA complex also supports this idea. Thus, the synaptic complex structure observed for XerH could equally well represent a stable intermediate that can reach the transient bent configuration required for cleavage on its own. Please resolve/comment on this issue.*

The reviewer is concerned about the possibility of "futile" DNA cleavage and ligation in the XerH-*difH* system. We have no evidence that this occurs in the XerH-*difH* system, but we cannot exclude the possibility based on our data. We now discuss the alternative possibilities raised by the reviewers in the manuscript.

*5) Authors\' response \#6. The reviewers requested that the authors note the possibility that the synaptic complex structure may be influenced by crystallization conditions (low pH and/or lack of divalents). The authors acknowledge this in their response to reviewers, but do not appear to have modified the manuscript. Given that this structure is central to the authors\' proposals for Xer recombination, the readers should be made aware that the conditions for the two structures are quite different. Please revise the manuscript accordingly.*

We now point out the difference in crystallization conditions in the manuscript as requested.

*6) The authors note that several unbound Xer crystal structures show different domain relationships, but continue to promote the idea that a specific conformational change takes place upon DNA binding (as shown in the video). To echo the original review, it is unlikely that the XerD alone structure represents a true \"conformational intermediate,\" rather than just one of an ensemble of configurations present when Xer subunits are not bound to dif. The three Xer crystal structures in the PDB have their NTDs in completely different conformations. The ideas in the discussion and video illustrating that the NTD has to undergo a significant change when completing the clamp on the dif half-site was assumed many years ago by most people in the field and is true for all tyrosine recombinases. This point should clarified or else its discussion (and the movie) should be removed from the paper.*

The respective discussion and movie have been removed in the current version of the manuscript.

*7) The distinction between understanding the mechanism of recombination vs. regulation of this process is important, but not made clear (Abstract and Introduction section). The authors imply that the mechanism of XerC/XerD recombination is still unknown.*

The last sentence of the Abstract has been rephrased to better distinguish between catalytic mechanism and its regulation; and the sentence that was in the Introduction has been deleted to avoid incorrect implications.

*8) Introduction paragraph six. The structures do not delineate the pathway (delete this) but do shed light on potential regulatory mechanisms (reword).*

Corrected.

*9) In the same section the structure does not explain why activation is required. It suggests a possible model, as described by the authors, which differs from at least one other XerCD model.*

Rephrased.

*10) Results paragraph one. The current mechanism is based on much more than the series of Cre-loxP structures cited. A review covering tyrosine recombinase mechanisms (there are many) might be more appropriate here.*

Corrected.

*11) Subsection "Structure of the XerH-difH synaptic complex" need to be redrafted to accurately to describe the historical record (in doing so, the authors should consider point 9 and earlier comments regarding alternative models). The current text is incomplete and in part misleading. In the absence of FtsK, HJs formed by XerC were detected in early work and this led to the hypothesis that the XerC active conformation formed preferentially and FtsK switched the conformation of an XerC active complex to one in which XerD was active. Single-molecule FRET experiments by Zawadzki and colleagues led to the different hypothesis that this is not the case; rather, the major synaptic complex that forms in the absence of FtsK is an \'XerD potentially active conformation,\' which is catalytically dead. A small proportion of XerC active complexes nevertheless form and are responsible for the XerC HJs. Nevertheless, the dominant pre-active XerD synaptic complexes are the ones activated by XerD. This is consistent with the results here, but the historical development of these ideas should be explicitly chronicled.*

We now describe the historical development of the available models for XerC/D activation in the current version of the manuscript as requested. (Results section first paragraph)

*12) Subsection "Structure of the XerH-difH synaptic complex" paragraph two. DNA duplex, not oligonucleotide.*

Done.
